![]() |
|
|
Vol. 304, Issue 1, 238-245, January 2003
Molecular Pharmacology Unit, Pharmaceutical Products Research,
Alcon Research, Ltd., Fort Worth, Texas
The ability of a number of prostaglandin F2
(PGF2
) analogs to mobilize intracellular
Ca2+ [Ca2+]i and to compete for
[3H]PGF2
binding to prostaglandin
F2
receptors (FP) was evaluated. Radioligand binding
studies measuring displacement of [3H]PGF2
by a variety of FP prostaglandin analogs yielded the following rank
order of affinities: travoprost acid
[(+)-16-m-trifluorophenoxy tetranor
PGF2
; (+)-fluprostenol] > bimatoprost acid
(17-phenyl-trinor PGF2
)
unoprostone
(13,14-dihydro-15-keto-20-ethyl PGF2
) = bimatoprost
(17-phenyl-trinor PGF2
ethyl amide)
Lumigan (bimatoprost ophthalmic solution). In FP functional studies, travoprost acid (EC50 = 17.5-37 nM, n = 13),
bimatoprost acid (EC50 = 23.3-49.0 nM,
n = 6-12), unoprostone (EC50 = 306-1270 nM, n = 4-8), bimatoprost (EC50 = 3070- 3940 nM, n = 4-9),
and Lumigan (EC50 = 1470-3190 nM,
n = 5-9) concentration dependently stimulated
[Ca2+]i mobilization via the rat (A7r5
cells), mouse (3T3 cells), and cloned human ocular FP prostanoid
receptors. The rank order of potency of these compounds at the FP
receptor of the three species was similar and in good agreement with
the determined binding affinities. The agonist effects of these
compounds were concentration dependently blocked by the FP
receptor-selective antagonist, AL-8810 (11
-fluoro-15-epi-15-indanyl-tetranor PGF2
)
(Ki = 0.6-1.3 µM). These studies
have demonstrated that bimatoprost, unoprostone, and bimatoprost acid
possess direct agonist activities at the rat, mouse, and human FP
prostanoid receptor and that travoprost acid is the most potent of the
synthetic FP prostaglandin analogs tested.
This article has been cited by other articles:
![]() |
C B Camras, N A Sharif, M B Wax, and J Stjernschantz Bimatoprost, the prodrug of a prostaglandin analogue Br. J. Ophthalmol., June 1, 2008; 92(6): 862 - 863. [Full Text] [PDF] |
||||
![]() |
L B Cantor Author's reply Br. J. Ophthalmol., June 1, 2008; 92(6): 863 - 864. [Full Text] [PDF] |
||||
![]() |
R.-F. Wang, D. J. Gagliuso, T. W. Mittag, and S. M. Podos Effect of 15-Keto Latanoprost on Intraocular Pressure and Aqueous Humor Dynamics in Monkey Eyes Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4143 - 4147. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Romano and M. D. Lograno Evidence for the Involvement of Cannabinoid CB1 Receptors in the Bimatoprost-Induced Contractions on the Human Isolated Ciliary Muscle Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3677 - 3682. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Sharif, C. R. Kelly, and M. McLaughlin Human Trabecular Meshwork Cells Express Functional Serotonin-2A (5HT2A) Receptors: Role in IOP Reduction. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 4001 - 4010. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Kelly and N. A. Sharif Pharmacological Evidence for a Functional Serotonin-2B Receptor in a Human Uterine Smooth Muscle Cell Line J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1254 - 1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Crowston, J. D. Lindsey, C. A. Morris, L. Wheeler, F. A. Medeiros, and R. N. Weinreb Effect of Bimatoprost on Intraocular Pressure in Prostaglandin FP Receptor Knockout Mice Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4571 - 4577. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Hebert, M. Carmosino, O. Saito, G. Yang, C. A. Jackson, Z. Qi, R. M. Breyer, C. Natarajan, A. N. Hata, Y. Zhang, et al. Characterization of a Rabbit Kidney Prostaglandin F2{alpha} Receptor Exhibiting Gi-restricted Signaling That Inhibits Water Absorption in the Collecting Duct J. Biol. Chem., October 14, 2005; 280(41): 35028 - 35037. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Nirodi, B. C. Crews, K. R. Kozak, J. D. Morrow, and L. J. Marnett The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells PNAS, February 17, 2004; 101(7): 1840 - 1845. [Abstract] [Full Text] [PDF] |
||||